EMUC19 is a frontline congress that identified optimal therapies and address gaps in clinical practices. This congress is designed to encourage relevant discussions on innovative treatment, the limits of standard therapies, and the impact of new research outcomes.

The congress brings together esteemed specialists and healthcare professionals from various disciplines, thanks to the collaborative efforts of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU).

The congress is accredited by the European Accreditation Council for Continuing Medical Education (an institution of the European Union of Medical Specialists) to provide CME activity for medical specialists.